Ask Warren

Boditech Med

206640 · KOSDAQ · ₩206640 · 바디텍메드

₩8,400▼ ₩160 (1.87%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩50B₩43B₩42B₩40B₩41B₩39B₩31B₩38B
Cost of sales₩21B₩18B₩18B₩16B₩18B₩15B₩15B₩14B
Gross profit₩30B₩25B₩24B₩24B₩24B₩24B₩16B₩23B
Operating income₩8.2B₩6.8B₩5.1B₩6.6B₩9.2B₩8.1B₩2.2B₩8.8B
Net income₩7.6B₩9.5B₩1.4B₩7.8B₩7.5B₩7.3B₩4.8B₩6.1B
Net income to shareholders₩7.3B₩9.6B₩1.3B₩7.8B₩7.3B₩7.3B₩4.8B₩6.1B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩304B₩296B₩282B₩275B₩262B₩259B₩255B₩247B
Current assets₩159B₩151B₩123B₩121B₩136B₩138B₩136B₩139B
Cash and equivalents₩38B₩40B₩20B₩17B₩41B₩43B₩48B₩36B
Total liabilities₩42B₩41B₩37B₩38B₩28B₩32B₩32B₩24B
Current liabilities₩29B₩27B₩23B₩24B₩24B₩28B₩27B₩20B
Borrowings₩16B₩12B₩15B₩15B₩6B₩5.5B₩8.8B₩3.8B
Total equity₩261B₩255B₩244B₩237B₩234B₩227B₩223B₩223B
Shareholders' equity₩247B₩242B₩231B₩223B₩220B₩214B₩210B₩211B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩444M₩4.7B₩10B₩111M₩5.4B₩6.1B₩9.1B₩4.6B
Capital spending₩2.3B₩5.1B₩4.2B₩24B₩3B₩2B₩3.5B₩3B
Free cash flow−₩2.8B−₩379M₩6.3B−₩24B₩2.4B₩4.1B₩5.6B₩1.5B
Dividends paid₩0₩3.3B₩0₩0₩150,000₩3.3B₩0₩0

Consolidated where available. Amounts in won.

Also known as: Boditech Med / 바디텍메드 / 206640 / KRX:206640

Source: KRX statistical information